Court Turner

Court R. Turner, J.D. joined Avalon Ventures in 2008 as an Advisor and became a Venture Partner in 2010.  Mr. Turner is President, CEO and Director of Carolus Therapeutics, COO of Afraxis, and Director of Zacharon Pharmaceuticals, each Avalon VIII portfolio companies. Additionally, Court led Avalon’s  investment in RQx Pharmaceuticals as its founding CEO and Chairman; and is COO and Director of Sova Pharmaceuticals, both Avalon IX portfolio companies.

Contact Court Turner